J0180 Agalsidase beta injection
Also known as: agalsidase beta, Fabrazyme
Agalsidase beta injection, a recombinant enzyme replacement therapy for Fabry disease.
In Plain Language
enzyme replacement for rare genetic disease; Fabry disease treatment
Clinical Context
Intravenous enzyme replacement therapy for Fabry disease (deficiency of alpha-galactosidase A). Reduces globotriaosylceramide accumulation in tissues, improving symptoms.
RVU Information
CPT J0180 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0180?
CPT J0180 (Agalsidase beta injection) is a J Codes (Drugs) code. Agalsidase beta injection, a recombinant enzyme replacement therapy for Fabry disease.
How is J0180 administered?
CPT J0180 is administered by a healthcare provider, typically via injection or infusion. Intravenous enzyme replacement therapy for Fabry disease (deficiency of alpha-galactosidase A). Reduces globotriaosylceramide accumulation in tissues, improving symptoms. It is used by Genetics, Nephrology, Internal Medicine.
When is CPT J0180 used?
Intravenous enzyme replacement therapy for Fabry disease (deficiency of alpha-galactosidase A). Reduces globotriaosylceramide accumulation in tissues, improving symptoms.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.